PCSK9 and familial hyperaldosteronism: Moreover, mutations in the LDLR, apolipoprotein B (APOB), and PCSK9 genes, which are known to cause FH through affecting LDL clearance, account for merely 2.5% of cases of LDL-C elevation [9].